Article

The SU.FOL.OM3 Study: a secondary prevention trial testing the impact of supplementation with folate and B-vitamins and/or Omega-3 PUFA on fatal and non fatal cardiovascular events, design, methods and participants characteristics

UMR U557 Inserm, U1125 Inra, Cnam, Université Paris 13, CRNH IdF, F-93017 Bobigny, France.
Trials (Impact Factor: 2.12). 02/2008; 9:35. DOI: 10.1186/1745-6215-9-35
Source: PubMed

ABSTRACT During the last decades, many basic and clinical research have pointed to the role of B vitamins (folate, vitamins B6 and B12) and n-3 fatty acids as nutritional factors that might have a protective effect on the development of cardiovascular diseases (CVD).
The SU.FOL.OM3 (SUpplementation with FOlate, vitamin B6 and B12 and/or OMega-3 fatty acids) trial is a randomized double-blind, placebo-controlled, secondary-prevention trial designed to test the efficacy of 5-methyl tetra-hydro-folates (5-MTHF) supplementation, in combination with vitamin B6 and B12 and/or n-3 fatty acids, at nutritional doses, on fatal and non fatal ischemic CVD in a 2 x 2 factorial design. A total of 2501 patients aged between 45 and 80 years who had a past history, in the previous year, of myocardial infarction (n = 1151) or instable angina pectoris (n = 711) or an ischemic stroke (n = 639) were included. Subjects have to be supplemented and followed up for five years. Daily supplementation comprised nutritional doses of 5-MTHF (560 microgram), vitamin B6 (3 mg) and B12 (20 microgram) and/or n-3 fatty acids (600 mg with an EPA:DHA ratio of 2:1). A factorial design 2 x 2 has been applied to investigate the separate effects of the B-vitamins, and the n-3 fatty acids, as well as their interaction as compared to the placebo.The primary endpoint is a combination of myocardial infarction, ischemic stroke and cardiovascular death. Secondary endpoints are events of the composite endpoint taken separately, total mortality, and other cardiovascular events such as acute coronary syndromes, coronary revascularization, cardiac failure, arrhythmia...
Baseline socio-demographic and medical characteristics of participants are totally comparable in the four randomized groups.
Current Controlled Trials ISRCTN41926726.

0 Followers
 · 
226 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Riassunto. Attualmente la medicina è finalizzata soprattut-to alla cura delle lesioni. È opportuno, invece, sviluppare il concetto di "cura della salute". Numerose autorità scientifi-che raccomandano un incremento dell'assunzione di acidi grassi essenziali omega-3 e di astaxantina per il manteni-mento della salute della popolazione generale. Gli omega-3 sono necessari per il potenziamento funzionale delle membrane cellulari, sia nel soggetto sano, sia in affetti da di-verse patologie croniche. È noto quanto benefico risulti un frequente, regolare consumo di pesce, alimento che è ricca sorgente di omega-3. L'astaxantina è dotata di una potente azione antiossidante comprovata in lavori sperimentali ed in studi clinici. Per la recente evidenza della contemporanea presenza di omega-3 e astaxantina in olio di salmone sel-vaggio Sockeye, è stata effettuata una revisione della lette-ratura al fine di valutare il possibile ruolo di tale associazio-ne nell'ambito di programmi per la promozione della salute. Parole chiave. Astaxantina, cura della salute, olio di sal-mone selvaggio Sockeye, omega-3, patologie croniche. Summary. Omega-3 fatty acids and astaxanthin in health and disease. Recent knowledges. At present, medicine is aimed to the treatment of lesions. Instead, it would be right to develop the maintenance of normal health. A number of authorities have recently rec-ommended increases in intake of omega-3 fatty acids and astaxanthin for the health of general population. Omega-3 are necessary to provide the optimal function of cellular membrane in health and in disease states. It is well known how at least two servings of fish a week, or dietary supple-mentation of fatty acids omega-3, should be taken to ob-tain the health benefits of this essential nutrient. Astaxan-thin is a powerful biological antioxidant. This property has been implicated in its various biological activities demon-strated in both experimental animals and clinical studies. For the recent evidence of the contemporary presence of omega-3 and astaxanthin in oil of Wild Pacific Salmon Sock-eye, a review has been effected for the evaluation of a pos-sible role of such association for the health promotion.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Algebraic structure of codes over Fq , closed under arbitrary abelian group G of permutations with exponent relatively prime to q, called G-invariant codes, is investigated using transform domain approach. In particular, this general approach unveils algebraic structure of quasicyclic codes, abelian codes, cyclic codes and quasi-abelian codes with restriction on G to appropriate special cases. Dual codes of G-invariant codes and self dual G-invariant codes are characterized. The number of G-invariant self dual codes for any abelian group G is found. In particular, this gives the number of self-dual l-quasi-cyclic codes of length ml over Fq when (m; q) = 1. Tanner's approach for getting a bound on the minimum distance from a set of parity check equations over an extension eld is extended and how it can be used to get a minimum distance bound for a G-invariant code is outlined. Karlin's decoding algorithm for a systematic quasi-cyclic code with single row of circulants in the generator matrix is extended to the case of systematic quasi-abelian codes. In particular, this can be used to decode systematic quasi-cyclic codes with columns of parity circulants in the generator matrix.
    Information Theory, 2002. Proceedings. 2002 IEEE International Symposium on; 02/2002
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Omega-3 fatty acids (omega-3 FAs) are essential fatty acids with diverse biological effects in human health and disease. Reduced cardiovascular morbidity and mortality is a well-established benefit of their intake. Dietary supplementation may also benefit patients with dyslipidaemia, atherosclerosis, hypertension, diabetes mellitus, metabolic syndrome, obesity, inflammatory diseases, neurological/ neuropsychiatric disorders and eye diseases. Consumption of omega-3 FAs during pregnancy reduces the risk of premature birth and improves intellectual development of the fetus. Fish, fish oils and some vegetable oils are rich sources of omega-3 FAs. According to the UK Scientific Advisory Committee on Nutrition guidelines (2004), a healthy adult should consume a minimum of two portions of fish a week to obtain the health benefit. This review outlines the health implications, dietary sources, deficiency states and recommended allowances of omega-3 FAs in relation to human nutrition.
    Postgraduate medical journal 03/2009; 85(1000):84-90. DOI:10.1136/pgmj.2008.073338 · 1.55 Impact Factor
Show more

Preview (3 Sources)

Download
0 Downloads
Available from